Cargando…
Variant histology in bladder cancer: diagnostic and clinical implications
Urothelial carcinoma differentiates into variant histological subtypes in approximately 25% of cases. Since every histological variant has unique characteristics, including metastatic potential, expression of immunotherapy targets, and susceptibility to radiation or chemotherapy, every variant offer...
Autores principales: | Black, Anna J., Black, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798576/ https://www.ncbi.nlm.nih.gov/pubmed/35117266 http://dx.doi.org/10.21037/tcr-20-2169 |
Ejemplares similares
-
Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020) -
Review of non-invasive urinary biomarkers in bladder cancer
por: Lee, Hyung-Ho, et al.
Publicado: (2020) -
Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020) -
Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020) -
The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020)